Close Menu

NEW YORK (360Dx) – A quantitative interferon-gamma release assay can identify young children with latent tuberculosis who are at risk of developing active cases of the disease, according to a new study.

The researchers added that their findings could lead to changes in international guidelines, which currently do not recommend the use of such tests in children.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.